Drug Trial Radar · NCT02319837
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,068
Actual
Start
Dec 17, 2014
Primary completion
Jan 31, 2023
Study completion Jul 30, 2027
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- Collaborators
- Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.
- First posted
- Dec 18, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both. The randomized / blinded portion of the study is now completed following primary endpoint analyses. The study remains ongoing in open label format.
Conditions
- Hormone Sensitive Prostate Cancer
- Prostate Cancer
- Cancer of the Prostate
Interventions
EnzalutamideDrug
Placebo (No longer applicable in Open Label study period)Drug
Sugar pill to mimic enzalutamide
Leuprolide Open LabelDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Metastasis-free Survival (MFS) Compared Between Enzalutamide Plus Leuprolide and Placebo Plus LeuprolideTime frame: From randomization until radiographic progression or death without radiographic progression, whichever occurred first (up to Month 98 when at least 197 MFS events occurred among the 3 treatment groups)
Locations
255 sites in 17 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
University of Alabama at Birmingham
Birmingham, Alabama
University of Alabama at Birmingham, IDS Pharmacy
Birmingham, Alabama
Alaska Urological Institute dba Alaska Clinical Research Center
Anchorage, Alaska
Arizona Urology Specialists
Tucson, Arizona
Tower Hematology Oncology Medical Group
Beverly Hills, California
Cedars-Senai OCC Pharmacy
Los Angeles, California
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute
Los Angeles, California
University of California, Irvine Medical Center
Orange, California
Sutter Medical Group, Vascular & Varicose Vein Center
Roseville, California
Sutter Medical Group
Roseville, California
UC Davis Comprehensive Cancer Center
Sacramento, California
University of California Davis Medical Center
Sacramento, California
University of California, Davis, School of Medicine
Sacramento, California
The Urology Center of Colorado
Denver, Colorado
Foothills Urology, P.C.
Golden, Colorado
Eastern Connecticut Hematology Oncology Associates
Norwich, Connecticut
Lakeland Regional Health Hollis Cancer Center
Lakeland, Florida
Emory University Hospital
Atlanta, Georgia
Winship Cancer Institute, Emory University
Atlanta, Georgia
Emory University Hospital
Atlanta, Georgia
Northwestern Medical Group
Chicago, Illinois
Northwestern Memorial Hospital
Chicago, Illinois
First Urology, PSC
Jeffersonville, Indiana
The University of Kansas Hospital
Kansas City, Kansas
Kansas City Urology Care, PA
Overland Park, Kansas
The University of Kansas Cancer Center and Medical Pavilion
Westwood, Kansas
GU Research Network/Wichita Urology Group
Wichita, Kansas
John Hopkins University Hospital
Baltimore, Maryland
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland
The Sidney Kimmel Cancer Center at Johns Hopkins Hospital- Oncology Investigational Drug Services
Baltimore, Maryland
Chesapeake Urology Research Associates
Towson, Maryland
Comprehensive Urology - Macomb Office
Macomb, Michigan
Comprehensive Urology - Royal Oak (Stephenson) office
Royal Oak, Michigan
GU Research Network, LLC / Urology Cancer Center
Omaha, Nebraska
VA Lahontan Valley Outpatient Clinic
Fallon, Nevada
Memorial Sloan Kettering Cancer Center Basking Ridge
Basking Ridge, New Jersey
Memorial Sloan Kettering Cancer Center Commack
Commack, New York
Memorial Sloan Kettering Cancer Center Westchester
Harrison, New York
Memorial Hospital
New York, New York
Showing 40 of 255 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.